VitaNova Life Sciences Corp
Close on Oct 19, 2026
- Market cap
- $37.52M
- P/E (TTM)
- –
- Dividend yield
- –
About VitaNova Life Sciences
Wholesale-Apparel, Piece Goods & Notions, SIC 5130
VitaNova Life Sciences Corporation is a consumer health, beauty, and lifestyle company that develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and healthy food products. Its core consumer-health operations function under a dual-brand system comprising GeneCode, an advanced science-oriented wellness brand, and AMZ, a high-volume functional-nutrition line. The company also trades healthy food items such as olive juice, white sesame oil, and aloe vera drinks, while maintaining a business consulting segment that advises third parties on funding and management. It primarily serves consumers through a business-to-business model alongside regional distributors and online channels.
The company operates under an asset-light model, relying on third-party contract manufacturers and logistics partners for production and fulfillment. In addition to direct-to-consumer sales in the United States, VitaNova distributes products internationally through cross-border e-commerce platforms. Its principal executive offices are located in New York, New York.
Summary of the business section of VitaNova Life Sciences's latest annual report, written by StockData.
Company profile
Company
- Legal name
- VitaNova Life Sciences Corp
- Founded
- 2017
- Headquarters
- New York, NY
- Address
- 39 E. Broadway, Ste 603 10002
- Phone
- (516) 886-8888
- Employees
- 7, Apr 30, 2026
- Industry
- Wholesale-Apparel, Piece Goods & Notions
- Incorporated in
- Nevada
- Fiscal year ends
- April 30
- Auditor
- Simon & Edward, LLP, Los Angeles County, California
Stock & identifiers
- Ticker
- VNOV
- Exchange
- OTC
- IPO date
- Apr 13, 2022
- Shares outstanding
- 8M, Sep 14, 2026
- Public float
- $24.12M, Oct 31, 2025
- Filer category
- Non-accelerated filer<br>Smaller reporting company
- Stock splits
- 1-for-3 reverse, Mar 16, 2026; 1-for-3 reverse, Jan 27, 2026
- SEC CIK
- 1699709
- EIN
- 35-2583762
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
VitaNova Life Sciences's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“Annual Report, we had a total of 7 full-time employees.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Jan 13, 2026 | Name change | Name changed from YIJIA GROUP CORP. to VitaNova Life Sciences Corp |
| Jun 10, 2024 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Dec 2, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Jun 11, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Jun 1, 2021 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Sep 15, 2020 | Late filing | Notification of late filing |
| Jul 29, 2020 | Late filing | Notification of late filing |
| Mar 16, 2020 | Late filing | Notification of late filing |
| Jul 29, 2019 | Late filing | Notification of late filing |
| Feb 27, 2019 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Nov 26, 2018 | Name change | Name changed from Soldino Group Corp to YIJIA GROUP CORP |
| Jul 19, 2018 | Auditor change | Change in certifying accountant (8-K Item 4.01) |
| Jun 25, 2018 | Auditor change | Change in certifying accountant (8-K Item 4.01) |